HC Wainwright & Co. Reiterates Buy on Korro Bio, Maintains $15 Price Target

Benzinga · 3d ago
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Korro Bio (NASDAQ:KRRO) with a Buy and maintains $15 price target.